Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
478 |
|
|||
481 |
|
|||
485 |
|
Pathway Name | Organism |
---|---|
Signaling by ALK fusions and activated point mutants | Homo sapiens |
Signaling by CSF1 (M-CSF) in myeloid cells | Homo sapiens |
Signaling by LTK | Homo sapiens |
Signaling by LTK in cancer | Homo sapiens |
Signaling by PDGFRA extracellular domain mutants | Homo sapiens |
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | Homo sapiens |
Synthesis of PIPs at the plasma membrane | Homo sapiens |
Tie2 Signaling | Homo sapiens |
VEGFA-VEGFR2 Pathway | Homo sapiens |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110758 | type 1 diabetes mellitus 21 | |
DOID:0110759 | type 1 diabetes mellitus 22 | |
DOID:0110760 | type 1 diabetes mellitus 23 | |
DOID:0110761 | type 1 diabetes mellitus 24 | |
DOID:0110858 | polycystic kidney disease 1 | |
DOID:0110892 | inflammatory bowel disease 1 | |
DOID:0110910 | leukocyte adhesion deficiency 1 | |
DOID:0111005 | cone-rod dystrophy 2 | |
DOID:0111029 | hemochromatosis type 1 | |
DOID:0111135 | congenital generalized lipodystrophy type 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024